The European Life Sciences Web Portal
This is a free web portal for the life sciences in Europe and Israel... » read more
- Cosmo Becomes Largest Shareholder of Paion (2016-06-24)
> Cosmo to make EUR 10 million upfront license fee payment to PAION > PAION entitled to receive up to EUR 42.5 million in milestone payments and significant double-digit tiered royalties > PAION resolves issuance of 5,064,194 new shares to a subsidiary of Cos...
- MolMed: Positive CHMP Opinion for Immunogene Therapy (2016-06-24)
MolMed receives positive CHMP opinion recommending conditional marketing authorisation for Zalmoxis®, the first immunogene therapy to treat high-risk haematological malignancies in patients receiving haplo-identical haematopoietic stem cell transplantation The...
- CRISPR Therapeutics Raises Additional $38m in Series B (2016-06-24)
Funding to Support the Development of its CRISPR/Cas9 Gene-Editing Platform and Programs CRISPR Therapeutics, a biopharmaceutical company focused on translating CRISPR/Cas9 gene-editing technology into transformative medicines, today announced an additional $3...
- Oxford Immunotec to Acquire Imugen for $22.2m in Cash (2016-06-23)
Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of immune-regulated conditions, today announced it has entered into a definitive agreement to acquire...
- Thermo and NIBRT Collaborate on Biopharma Characterisation (2016-06-23)
Analytical solutions designed to streamline workflows, quickly generate data for deeper understanding of molecular complexes Thermo Fisher Scientific, the world leader in serving science, and the National Institute for Bioprocessing Research and Training (NIBR...
- Qiagen Completes Tender Offer for Shares in Exiqon A/S (2016-06-23)
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the successful completion of the conditional, voluntary public tender offer for the shares in Exiqon A/S, a world leader in RNA technology. The extended Offer Period expired yesterday, on 22 ...
- Cobra Biologics and Alligator Bioscience Extend Partnership (2016-06-23)
Project will deliver second cell line for manufacture of immuno-oncology antibody ADC-1015 following ADC-1013 success Cobra Biologics, an international CDMO of biologics and pharmaceuticals, has been contracted to develop a second cell line for Alligator Biosc...
- M4I Institute Becomes Waters Centers of Innovation (2016-06-22)
Institute Develops Medical Applications for Mass Spectrometry to Understand the Molecular Underpinnings of Cancer and Other Diseases At a ceremony and symposium at Maastricht University, The Netherlands, Waters Corporation (NYSE:WAT) officially welcomed the Ma...
- TxCell Exercises Option for Weizmann CAR-Treg Patent (2016-06-21)
Strengthened IP position further enhances TxCell's first mover advantage in the promising CAR-Treg space TxCell SA (FR0010127662 – TXCL), a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T cells (Treg) to tr...
- Adaptimmune to Use Thermo’s Dynabeads CD3/CD28 CTS (2016-06-21)
Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that it has entered into a commercial development and supply agreement with Thermo Fisher Scientific. The new 10-year agreement augments Adaptimmune’s exclusive ...
Life-Sciences-Europe.com is your doorway to the European life sciences!
[LSE] provides free, up-to-date and structured access to
in Europe and Israel.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!Start here with the latest News!
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to firstname.lastname@example.org and simply fill the subject line with the word »LSE newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]